Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Miliarial gout (a new entity).

Rahul Shukla1, Ronald B Vender, Ayman Alhabeeb

  • 1Department of Medicine, Mcmaster University, Hamilton, ON, Canada.

Journal of Cutaneous Medicine and Surgery
|February 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.

The British journal of dermatology·2026
Same author

Design of a novel nano-lipoidal gel system for topical delivery of hydroxychloroquine in rheumatoid arthritis.

Journal of drug targeting·2026
Same author

Pathophysiology and Molecular Signalling in Osteoporosis: Linking Risk Factors to Bone Loss.

Journal of cellular and molecular medicine·2026
Same author

Nanotherapeutic strategies for mitigating sepsis-induced multiorgan dysfunctions.

Nanomedicine (London, England)·2026
Same author

Si ← N Dative Tetrel Bonding in Anionic Bis(catecholato)silicates: Role of Local Electronic Anisotropy.

The journal of physical chemistry. A·2026
Same author

Evaluation of Injection Site Pain and Adherence in Patients Transitioning from a High to Low Volume Adalimumab Formulation (AVT02, Simlandi®) Across Multiple Indications (EASE PAIN).

Rheumatology and therapy·2026
Same journal

Limitations in the Evidence Base for Bruton Tyrosine Kinase Inhibitors in Chronic Spontaneous Urticaria.

Journal of cutaneous medicine and surgery·2026
Same journal

Adult Cutaneous Chronic Graft-Versus-Host Disease: An In-Depth Review.

Journal of cutaneous medicine and surgery·2026
Same journal

'Cockade' or 'Targetoid' Variant of Syphilis.

Journal of cutaneous medicine and surgery·2026
Same journal

Tinea Imbricata.

Journal of cutaneous medicine and surgery·2026
Same journal

Intergenerational Clouston Syndrome.

Journal of cutaneous medicine and surgery·2026
Same journal

Herpes Zoster Ophthalmicus-Associated Trigeminal Trophic Syndrome.

Journal of cutaneous medicine and surgery·2026
See all related articles

Miliarial gout, a rare intradermal manifestation of tophaceous gout, presents as tiny papules. This condition, linked to risk factors like renal insufficiency, responds to allopurinol treatment.

Area of Science:

  • Dermatology
  • Rheumatology
  • Gout Pathophysiology

Background:

  • Tophaceous gout typically involves subcutaneous monosodium urate crystal deposits.
  • Intradermal gout manifestations are uncommon, with miliarial gout previously unreported.

Observation:

  • This study describes the first known case of miliarial gout.
  • Miliarial gout presents as multiple tiny, white-to-cream papules on an erythematous base.

Findings:

  • Miliarial gout is an intradermal phenomenon.
  • Risk factors include renal insufficiency, hypertension, diuretic use, long disease duration, and inconsistent urate-lowering therapy.
  • Allopurinol administration was effective in treating miliarial gout.

Implications:

Related Experiment Videos

  • Miliarial gout represents a unique cutaneous manifestation of tophaceous gout.
  • Understanding risk factors can aid in early identification and management of intradermal gout.
  • This finding expands the spectrum of cutaneous presentations in gout.